Location History:
- Seoul, KR (2017)
- Hwaseong-si, KR (2018)
Company Filing History:
Years Active: 2017-2018
Title: Seungja Oh: Innovator in Cancer Treatment
Introduction
Seungja Oh is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, his work focuses on developing therapies that target specific cancer pathways.
Latest Patents
Seungja Oh's latest patents include a combination therapy using a dual inhibitor of c-MET and EGFR, as well as an IGF-1R inhibitor. This method aims to prevent and treat cancer by co-administering these inhibitors to patients in need. His second patent involves an anti-c-Met/anti-Ang2 bispecific antibody, which includes both an anti-c-Met antibody and an anti-Ang2 antibody. This invention also encompasses a pharmaceutical composition and a method for utilizing the bispecific antibody in treatment.
Career Highlights
Seungja Oh is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of medical innovation. His work is characterized by a commitment to improving cancer therapies and enhancing patient outcomes.
Collaborations
Seungja collaborates with notable colleagues, including Kyung Ah Kim and Bo Gyou Kim. Their combined expertise contributes to the advancement of research and development in cancer treatment.
Conclusion
Seungja Oh's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the field. His work at Samsung Electronics Co., Ltd. and collaborations with esteemed colleagues further emphasize his commitment to advancing medical science.